- Several prominent Wall Street financial institutions recently updated their price targets and ratings for multiple publicly traded companies.
- Major adjustments include JP Morgan raising Amazon's price target to $ 365, while HC Wainwright & Co. downgraded Karyopharm Therapeutics and slashed its target to $ 3.
- Additional rating changes involved firms such as Barclays, Needham, Morgan Stanley, and Deutsche Bank adjusting their outlooks for various sector stocks.